Medtronic's defender embolism prevention device:
This article was originally published in Clinica
Medtronic has CE marked its Defender embolic protection filter for sale in Europe. The technology is now launched in Europe for use during minimally-invasive procedures in carotid arteries, such as the implantation of stents, and saphenous vein grafts. The filter has already been used in procedures conducted by interventional cardiologists and vascular surgeons in Germany and Spain, the Minneapolis, Minnesota firm said. Made of braided Nitinol, the Defender has a peel-away delivery sheath that enables physicians to manoeuvre the device easily across lesions to the desired location. When opened, the filter acts as a basket, allowing blood flow while trapping embolic debris that may become dislodged during the stenting procedure. The Defender filter is not on sale in the US.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.